HQL   $15.54  -0.13% Market Open

Tekla Life Sciences Investors
Total Cash
totalCashPerShare
EBITDA
Total Debt 0.00
quickRatio 0.001
currentRatio 0.268
Total Revenue 3.51M
debtToEquity
Revenue/Share 0.134
ROA -0.00318
ROE 0.01281
grossProfits
freeCashflow
operatingCashflow
earningsGrowth 0.42
revenueGrowth 0.07
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -0.31634
profitMargins 1.5645399
enterpriseValue
forwardPE
floatShares
sharesOutstanding 27.35M
sharesShort 221.52K
sharesShortPriorMonth 264.12K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.37%
Short Ratio help_outline 2.48%
shortPercentOfFloat
impliedSharesOutstanding
bookValue 16.126
Price To Book help_outline 0.95
earningsQuarterlyGrowth 0.49
netIncomeToCommon 5.50M
trailingEps 1.34%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 84
lastUpdated Sept. 16, 2024, 11:41 a.m.